Medix Inc. (TYO:331A)

Medix Income Statement

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018
Revenue	14,392	11,979	15,440	15,163	12,488
Revenue Growth (YoY)	20.14%	-22.41%	1.83%	21.42%	21.39%
Cost of Revenue	11,102	9,231	12,410	12,231	10,044
Gross Profit	3,290	2,748	3,029	2,932	2,444
Other Operating Expenses	2,719	2,577	2,376	2,266	1,957
Operating Expenses	2,791	2,647	2,438	2,311	1,994
Operating Income	498.99	101.23	591.55	621.57	449.82
Interest Expense	-4.4	-8.62	-9.81	-8.8	-9.99
Other Non Operating Income (Expenses)	-42.35	-264.8	-445.86	-45.89	-152.28
Pretax Income	452.23	-172.19	135.88	566.88	287.56
Income Tax Expense	317.92	-54.58	33.25	177.05	73.66
Net Income	134.32	-117.62	102.63	389.83	213.9
Net Income to Common	134.32	-117.62	102.63	389.83	213.9
Net Income Growth	-	-	-73.67%	82.25%	64.28%
Gross Margin	22.86%	22.94%	19.62%	19.34%	19.57%
Operating Margin	3.47%	0.84%	3.83%	4.10%	3.60%
Profit Margin	0.93%	-0.98%	0.66%	2.57%	1.71%
EBITDA	571.19	171.76	653.35	666.31	486.97
EBITDA Margin	3.97%	1.43%	4.23%	4.39%	3.90%
EBIT	498.99	101.23	591.55	621.57	449.82
EBIT Margin	3.47%	0.84%	3.83%	4.10%	3.60%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.